Traws Pharma, Inc. – NASDAQ:TRAW
Traws Pharma stock price today
Traws Pharma stock price monthly change
Traws Pharma stock price quarterly change
Traws Pharma key metrics
Market Cap | 48.71M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.87 |
Revenue | 226K |
EBITDA | -19.35M |
Income | -18.15M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -8564.6% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTraws Pharma stock price history
Traws Pharma stock forecast
Traws Pharma financial statements
| Jun 2023 | 57K | -4.25M | -7456.14% |
|---|---|---|---|
| Sep 2023 | 57K | -4.73M | -8314.04% |
| Dec 2023 | 56K | -4.18M | -7471.43% |
| Mar 2024 | 56K | -4.98M | -8898.21% |
| 2025 | 300K | -17.42M | -5806.92% |
|---|---|---|---|
| 2026 | 300K | -17.00M | -5666.99% |
| 2027 | 300K | -19.93M | -6646.47% |
| 2028 | 400K | -24.34M | -6086.77% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 30468000 | 11.57M | 37.97% |
|---|---|---|---|
| Sep 2023 | 27038000 | 12.52M | 46.31% |
| Dec 2023 | 22683000 | 12.01M | 52.95% |
| Mar 2024 | 18172000 | 12.15M | 66.9% |
| Jun 2023 | -4.49M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | -4.46M | -14K | 0 |
| Dec 2023 | -4.43M | 0 | 0 |
| Mar 2024 | -4.42M | 0 | 0 |
Traws Pharma alternative data
| Jun 2024 | 17 |
|---|---|
| Jul 2024 | 17 |
Traws Pharma other data
| Period | Buy | Sel |
|---|
Monday, 30 December 2024 | ||
| Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval | prnewswire.com | |
Monday, 23 December 2024 | ||
| Traws Pharma stock soars 200% on encouraging bird flu drug data | invezz.com | |
| Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu | prnewswire.com |
-
What's the price of Traws Pharma stock today?
One share of Traws Pharma stock can currently be purchased for approximately $1.36.
-
When is Traws Pharma's next earnings date?
Unfortunately, Traws Pharma's (TRAW) next earnings date is currently unknown.
-
Does Traws Pharma pay dividends?
No, Traws Pharma does not pay dividends.
-
How much money does Traws Pharma make?
Traws Pharma has a market capitalization of 48.71M.
-
What is Traws Pharma's stock symbol?
Traws Pharma, Inc. is traded on the NASDAQ under the ticker symbol "TRAW".
-
How do i buy shares of Traws Pharma?
Shares of Traws Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Traws Pharma have?
As Jul 2024, Traws Pharma employs 17 workers.